CANCER AND THE UNCOMFORTABLE TRUTH
Money and Results
Over the past fifty years, more than one trillion dollars has been spent on the “War on Cancer.” Despite this investment, overall cancer rates have not declined. Age-adjusted incidence for many cancers has risen since 1971. If any other industry produced such outcomes after that level of spending, it would be regarded as a structural failure.
Where the Money Goes
More than 95 percent of funding continues to focus on treatment and pharmaceutical development rather than prevention. Less than five percent is allocated to studying environmental and nutritional causes. The system is shaped by what can be patented, marketed, and sold. The U.S. cancer treatment economy alone exceeds two hundred billion dollars annually. Eliminating the disease would dismantle the revenue structure that sustains it.
Known Causes of Cancer
Cancer is not random. Decades of research connect risk to diet, toxins, and environmental exposure. Key contributors include:
- Processed food, refined sugar, and seed oils
- Pesticides such as glyphosate and atrazine
- Industrial chemicals and PFAS
- Air pollution and heavy metals
- Certain forms of radiation exposure
- Toxic ingredients in food, water, and personal care products
These are not controversial findings. They are repeatedly confirmed in toxicology and public-health literature yet remain peripheral to mainstream cancer policy.
The Ingredients We Overlook
Regulatory agencies assess vaccines, pharmaceuticals, and household chemicals separately, but their combined biological load is rarely studied. Within vaccines, a few components deserve continued evaluation, not because they are proven carcinogens but because of their biological activity.
Aluminum adjuvants persist in tissues and promote local inflammation, which can influence immune signaling. Current evidence does not show a direct carcinogenic effect, but questions remain about cumulative exposure.
Thimerosal (ethyl-mercury) remains in some multi-dose influenza vaccines. Its short half-life reduces accumulation risk, yet it remains biologically active and merits continued monitoring.
Formaldehyde is a known carcinogen at high chronic exposure levels. The trace amounts used in vaccine production are far below those thresholds but are worth noting as part of total body burden.
Polysorbate 80 can increase cell permeability in high concentrations used for drug delivery. Vaccine-level quantities are much smaller, but cumulative effects in sensitive populations are not fully studied.
Residual DNA fragments from human or animal cell lines are strictly limited and degraded, yet ongoing transparency in testing remains essential.
Historical contamination incidents such as SV40 in early polio vaccines showed the need for vigilance. Later analyses did not find higher cancer rates, but they remind us that oversight must be uncompromising.
The current scientific consensus finds no direct carcinogenic link from modern vaccines as a class. Still, independent long-term evaluation is justified, especially regarding adjuvant load, immune modulation, and cross-reactivity. Oversight should not be left solely to the industries that profit from production.
What Gets Ignored
There are few serious national efforts to remove carcinogens from daily life. Pesticides that are linked to cancer remain approved. Thousands of industrial chemicals enter commerce without adequate testing. Food and personal-care industries face minimal accountability. Many corporations that profit from cancer treatment also manufacture or distribute the chemicals that increase cancer risk.
The Systemic Problem
A healthy population is not profitable. Chronic illness generates continuous revenue. Cancer patients spend an average of more than one hundred fifty thousand dollars on treatment. The structure rewards management over prevention. This is not a conspiracy; it is an economic alignment that prioritizes revenue stability over public health outcomes.
Public Messaging
Common talking points repeat year after year. “We are making progress.” Yet overall incidence continues upward. “We need more funding.” Yet a trillion dollars has not reversed the trend. “It is too complex.” Yet the core causes are known. “Run for the cure.” Yet prevention remains sidelined. Individual blame is emphasized while corporate and environmental accountability are avoided.
What Real Prevention Would Require
If the true goal were to reduce cancer rates, policies would focus on removing carcinogenic substances from food, water, and soil. They would ban toxic pesticides, regulate industrial emissions, subsidize organic agriculture, and educate the public on nutrition and detoxification. The total cost would be a fraction of what is spent each year on treatment and pharmaceutical research.
A Trillion in Perspective
One million seconds equal 11.5 days, while one trillion seconds equals more than thirty-one thousand years. Spending one million dollars every day would take nearly three thousand years to reach one trillion. That amount could have provided clean water, safe food, and environmental restoration worldwide, several times over. After that investment, the increase in cancer incidence cannot be explained by chance. It reflects a misaligned goal: the management of disease, not its elimination.
A Practical Path Forward
When cancer is diagnosed, the first step is to remove what created the conditions for its development. The human body possesses powerful regenerative capacity when it is no longer overwhelmed by toxins, processed food, and chronic stress. A restorative program emphasizes organic whole foods, pure water, clean air, natural sunlight, adequate rest, exercise, and emotional stability.
Chemotherapy, radiation, and surgery remain the profitable mainstays of modern oncology. They may be necessary in some cases, but the immune system that prevents recurrence depends on nutrition, detoxification, and emotional coherence.
The Emotional Component
Most people struggle to sustain healthy routines because of unresolved emotional patterns that drive self-sabotage. The Emotion Link and Ultimate Exercise frameworks identify and transform those underlying patterns, linking behavior, belief, and physiology. True prevention requires not only physical detoxification but also emotional clarity.
Conclusion
Fifty years and a trillion dollars later, cancer remains a growing epidemic. The problem is not ignorance but incentive. Until funding shifts from treatment to prevention and from profit to genuine public health, outcomes will not change. Health is not waiting for another drug. It is waiting for honesty, accountability, and a return to biological and emotional fundamentals.
References
- 1. U.S. Food and Drug Administration. Guidance for Industry: S1B Testing for Carcinogenicity of Pharmaceuticals. July 1997.
- 2. U.S. Food and Drug Administration. S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals. November 2022.
- 3. Beasley RA, et al. Preclinical Toxicology of Vaccines. Drug Saf. 2020;43(4):301-316.
- 4. Gupta RK. Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs. Drug Saf. 2010;33(4):243-255.
- 5. World Health Organization. Adjuvants — Global Advisory Committee on Vaccine Safety. June 2012.
- 6. Magistrado DJ, et al. Aluminium Adjuvants Versus Placebo or No Intervention in Vaccines: Systematic Review and Meta-Analysis. BMJ Open 2022;12:eXXXX.
- 7. Hviid A, et al. No Association Between Early Childhood Exposure to Aluminium Adjuvanted Vaccines and Risk of Chronic Conditions. Ann Int Med. 2025;182(2):123-130.
- 8. U.S. Food and Drug Administration. Final FL SG Response 12/14/2023 – mRNA COVID-19 Vaccines. December 2023.
- 9. De Souza HF. Aluminum in Vaccines: Mechanisms, Myths, and Safety Data. News-Medical. 2025.
- 10. Centers for Disease Control and Prevention. Adjuvants-Vaccine Safety. October 2024.
Mark Colafranceschi, D.C. • Licensed Chiropractic Physician – Arizona License #009154 • Scottsdale, Arizona